The 5-year analysis of Syncom Healthcare Ltd's performance infers:
We analysed the performance of Syncom Healthcare Ltd share prices over the last 10 years. Here is what we found out:
The Company was originally incorporated as Syncom Healthcare Limited on July 29, 2002 by Registrar of Companies, Maharashtra, Mumbai. The Certificate for Commencement of business was granted on August 2, 2002. The company has been promoted by Ajay Bankda & Jyoti Bankda. The company was formed for manufacturing, marketing & trading of pharmaceuticals formulations under its own brands in Ethical, OTC, Generic and Herbal market segment.
Initially it started its journey with the
Initially it started its journey with the marketing of the pharmaceuticals products manufactured by others under its own brand and in year 2006, the company set up a State of Art manufacturing unit at Dehradun in Uttarakhand. The unit was commissioned in November, 2006. During the year ended March 31, 2007, the net profit before tax & extra-ordinary items, of the Company increased to Rs.331.38 lakh from Rs.32.20 lakh during the year ended March 31, 2006 due to commencement of manufacturing of the various products in its own manufacturing unit and marketing through a strong distribution network.
SHL started as a marketing Company, which was outsourcing its requirement of finished products (Under Its Own Brand And Drug License) from other formulation manufacturing units based in and around Indore. Presently also SHL is outsourcing some of its requirement of finished products. With these companies, Syncom has a purchase and sale arrangement where the supplier unit is manufacturing SHLâ€™s products on SHLâ€™s specification and under SHLâ€™s quality control under which SHL controls the quality of raw material, their sourcing by the supplier as well as production in the units of these suppliers. The manufactured goods, manufactured for SHL are sold to SHL on pre-decided order prices for each formulation product so manufactured.
To cater the diversified and increased demand the Company planned to set up its own pharmaceutical manufacturing facilities. Accordingly, the company set up a manufacturing facility at Dehradun in the state of Uttrakhand, which is a Tax free & duty free Zone. The Company set up its Plant at Dehradun and it started the commercial production in November, 2006. Presently Company is Manufacturing, Marketing and Distributing its Pharmaceutical Formulations under own Brands of Ethical, OTC, Generic and Herbal market segment.
Product range of the company:
Syncom has presence in Pharmaceuticals Formulations which can be categorized in 4 broad categories i.e. Generic, OTC, Ethical and Herbal. The company manufactures a range of products such as Ethical drugs, Generic drugs, over the counter drugs (OTC) and Herbal formulations in various dosage forms and markets them under the trade mark â€˜Syncomâ€™ which is a registered trademark in the name of Syncom Healthcare Limited. The company also undertakes contract manufacturing for large variety of pharmaceutical formulations for a number of other pharmaceutical companies of national and international repute such as Lupin Limited, Nicholas Piramal India Ltd, Galpha Laboratories Limited, Percos India Pvt. Ltd etc. (under their own brands) located in India.
The company manufactures various dosage forms, which include tablets, capsules, eye/ear drops, ointment and creams and dry syrups. The company has an established product-marketing network covering both metro and minimetro cities, which enable it to reach the existing and potential customers through the network of distributors and dealers spread across the country. For the purpose of marketing the various products, the Companyâ€™s business has been categorized as Branded Generic Division, Over the Counter (OTC), Ethical division and Contract Manufacturing Division.
The Company is producing more than 130 products in Generic segment which includes CTZ, Profeed, Nimjet, Divoron, Gentijet, Ciprojet, etc.
Apart form Generic, the Company has developed presence in OTC Segment. The Company is producing more than 40 products in this segment which include Fastac, Q-coril, Triple action, Pandrop, Syncom Gripe Water, etc. Having built-up a presence in Generic & OTC segment and as a measure to expand and grow, the Company has also entered into Ethical segment. Syncom has developed more than 20 products in this segment which includes Fresca, Flusa, Nutone, Busera, etc.
Syncom is also having presence in Herbal segment with around 25 products which includes Patton, Attom, Narisudha, Salony Cream, etc.